- Home
- CPIX vs ESLA Comparison
CPIX vs ESLA Comparison
Compare CPIX & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- ESLA
- Stock Information
- Founded
- CPIX 1999
- ESLA 2021
- Country
- CPIX United States
- ESLA United States
- Employees
- CPIX N/A
- ESLA N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPIX Health Care
- ESLA Health Care
- Exchange
- CPIX Nasdaq
- ESLA Nasdaq
- Market Cap
- CPIX 51.5M
- ESLA 48.9M
- IPO Year
- CPIX 2009
- ESLA N/A
- Fundamental
- Price
- CPIX $2.17
- ESLA $2.55
- Analyst Decision
- CPIX
- ESLA Strong Buy
- Analyst Count
- CPIX 0
- ESLA 1
- Target Price
- CPIX N/A
- ESLA $16.00
- AVG Volume (30 Days)
- CPIX 46.5K
- ESLA 510.7K
- Earning Date
- CPIX 11-04-2025
- ESLA 11-13-2025
- Dividend Yield
- CPIX N/A
- ESLA N/A
- EPS Growth
- CPIX N/A
- ESLA N/A
- EPS
- CPIX N/A
- ESLA N/A
- Revenue
- CPIX $41,278,349.00
- ESLA N/A
- Revenue This Year
- CPIX N/A
- ESLA N/A
- Revenue Next Year
- CPIX N/A
- ESLA N/A
- P/E Ratio
- CPIX N/A
- ESLA N/A
- Revenue Growth
- CPIX 12.21
- ESLA N/A
- 52 Week Low
- CPIX $1.04
- ESLA $0.70
- 52 Week High
- CPIX $7.25
- ESLA $3.15
- Technical
- Relative Strength Index (RSI)
- CPIX 26.09
- ESLA 57.95
- Support Level
- CPIX $1.96
- ESLA $2.20
- Resistance Level
- CPIX $3.40
- ESLA $3.01
- Average True Range (ATR)
- CPIX 0.21
- ESLA 0.42
- MACD
- CPIX -0.13
- ESLA -0.01
- Stochastic Oscillator
- CPIX 10.13
- ESLA 51.33
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.